These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20332770)

  • 21. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole.
    Holtmann G; Cain C; Malfertheiner P
    Gastroenterology; 1999 Jul; 117(1):11-6. PubMed ID: 10381904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors.
    Pantoflickova D; Dorta G; Ravic M; Jornod P; Blum AL
    Aliment Pharmacol Ther; 2003 Jun; 17(12):1507-14. PubMed ID: 12823153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of long-term therapy with proton pump inhibitors on meal stimulated gastrin.
    Helgadóttir H; Metz DC; Yang YX; Rhim AD; Björnsson ES
    Dig Liver Dis; 2014 Feb; 46(2):125-30. PubMed ID: 24210828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Withdrawing PPI therapy after healing esophagitis does not worsen symptoms or cause persistent hypergastrinemia: analysis of dexlansoprazole MR clinical trial data.
    Metz DC; Pilmer BL; Han C; Perez MC
    Am J Gastroenterol; 2011 Nov; 106(11):1953-60. PubMed ID: 21844923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
    Lamouliatte H; Samoyeau R; De Mascarel A; Megraud F
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1523-30. PubMed ID: 10571611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An ascending single-dose safety and tolerance study of an oral formulation of rabeprazole (E3810).
    Lew EA; Barbuti RC; Kovacs TO; Sytnic B; Humphries TJ; Walsh JH
    Aliment Pharmacol Ther; 1998 Jul; 12(7):667-72. PubMed ID: 9701531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1-11 months old with symptomatic GERD.
    Winter H; Kum-Nji P; Mahomedy SH; Kierkus J; Hinz M; Li H; Maguire MK; Comer GM
    J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):609-18. PubMed ID: 20400912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized controlled trial of adding intravenous pantoprazole to conventional treatment for the immediate relief of dyspeptic pain.
    Musikatavorn K; Tansangngam P; Lumlertgul S; Komindr A
    Am J Emerg Med; 2012 Nov; 30(9):1737-42. PubMed ID: 22463973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pantoprazole versus omeprazole in the treatment of acute gastric ulcers.
    Witzel L; Gütz H; Hüttemann W; Schepp W
    Aliment Pharmacol Ther; 1995 Feb; 9(1):19-24. PubMed ID: 7766739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of preoperative intravenous pantoprazole in elective-surgery patients: a pilot study.
    Pisegna JR; Karlstadt RG; Norton JA; Fogel R; Oh DS; Jay Graepel G; Dorr MB
    Dig Dis Sci; 2009 May; 54(5):1041-9. PubMed ID: 18754096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
    Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trial.
    Compare D; Rocco A; Sgamato C; Coccoli P; Campo SM; Nazionale I; Larussa T; Luzza F; Chiodini P; Nardone G
    Dig Liver Dis; 2015 Apr; 47(4):273-9. PubMed ID: 25660822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton Pump Inhibitors Reduce Duodenal Eosinophilia, Mast Cells, and Permeability in Patients With Functional Dyspepsia.
    Wauters L; Ceulemans M; Frings D; Lambaerts M; Accarie A; Toth J; Mols R; Augustijns P; De Hertogh G; Van Oudenhove L; Tack J; Vanuytsel T
    Gastroenterology; 2021 Apr; 160(5):1521-1531.e9. PubMed ID: 33346007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease.
    Brunner G; Athmann C; Schneider A
    Aliment Pharmacol Ther; 2012 Jul; 36(1):37-47. PubMed ID: 22531114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival of the probiotic, L. plantarum 299v and its effects on the faecal bacterial flora, with and without gastric acid inhibition.
    Goossens D; Jonkers D; Russel M; Thijs A; van den Bogaard A; Stobberingh E; Stockbrügger R
    Dig Liver Dis; 2005 Jan; 37(1):44-50. PubMed ID: 15702859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pantoprazole improves glycemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Singh PK; Hota D; Dutta P; Sachdeva N; Chakrabarti A; Srinivasan A; Singh I; Bhansali A
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2105-8. PubMed ID: 22904177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.
    Ramdani A; Mignon M; Samoyeau R
    Gastroenterol Clin Biol; 2002 Apr; 26(4):355-9. PubMed ID: 12070410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
    Devault KR
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of pantoprazole on insulin secretion in drug-naïve patients with type 2 diabetes.
    González-Ortiz M; Martínez-Abundis E; Mercado-Sesma AR; Álvarez-Carrillo R
    Diabetes Res Clin Pract; 2015 Apr; 108(1):e11-3. PubMed ID: 25704601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study.
    Ang TL; Fock KM; Teo EK; Chan YH; Ng TM; Chua TS; Tan JY
    J Gastroenterol; 2006 Jul; 41(7):647-53. PubMed ID: 16933001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.